This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Able Corporation, Kobe University. Active years: 2026.
Company Filing History:
1 out of 19 
1 out of 143 
Years Active: 2026
Title: Shutaro Ishikawa: Innovator in Virus Inactivation Methods
Introduction
Shutaro Ishikawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods for virus inactivation and protein drug manufacturing. His innovative approach has the potential to enhance the safety and efficacy of therapeutic solutions.
Latest Patents
Shutaro Ishikawa holds a patent for a virus inactivation method, which includes a process for manufacturing protein drugs and a system for purifying solutions. The method involves irradiating a solution containing an artificially expressed antibody or antibody fragment with ultraviolet rays in the presence of a radical scavenger. This technique ensures that only 5% or less of the antibody or antibody fragment aggregates. The ultraviolet rays used have a wavelength ranging from 200 nm to 315 nm, with an irradiation amount of 300 mJ/cm or more and an irradiation time of 3 minutes or less. Additionally, the concentration of the radical scavenger in the solution is maintained at 0.03 mM or more.
Career Highlights
Throughout his career, Shutaro Ishikawa has worked with reputable organizations, including Able Corporation and Kobe University. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in his field.
Collaborations
Shutaro Ishikawa has collaborated with notable colleagues such as Kazuhisa Uchida and Satoshi Tomita. These partnerships have fostered an environment of innovation and have led to advancements in their respective areas of expertise.
Conclusion
Shutaro Ishikawa's work in virus inactivation methods and protein drug manufacturing showcases his dedication to improving biotechnological processes. His innovative contributions continue to influence the field and hold promise for future advancements.